Firm Capital Mortgage Investment Corporation (FC:CA) is expected to report for Q2 2024
Brookfield Asset Management Ltd. Class A Limited Voting Shares (BAM:CA) is expected to report $0.43 for Q3 2023
Economic Investment Trust Limited (EVT:CA) is expected to report for quarter end 2023-09-30
United Corporations Limited (UNC:CA) is expected to report for quarter end 2023-09-30
TriStar Gold Inc. (TSG:CA) is expected to report for Q2 2024
Coveo Solutions Inc. Subordinate voting shares (CVO:CA) is expected to report $-0.03 for Q2 2024
Altius Renewable Royalties Corp. (ARR:CA) is expected to report $0.03 for Q3 2023
Burcon Nutrascience Corporation (BU:CA) is expected to report for Q1 2024
Volatus Aerospace Corp. (VOL:CA) is expected to report $-0.01 for Q3 2023
CT Real Estate Investment Trust (CRT.UN:CA) is expected to report $0.33 for Q3 2023
European Residential Real Estate Investment Trust (ERE.UN:CA) is expected to report $0.06 for Q3 2023
Ivanhoe Mines Ltd. (IVN:CA) is expected to report $0.11 for Q3 2023
Dream Impact Trust (MPCT.UN:CA) is expected to report $-0.23 for Q3 2023
Element Fleet Management Corp. (EFN:CA) is expected to report $0.33 for Q3 2023
Chesswood Group Limited (CHW:CA) is expected to report $-0.04 for Q3 2023
MEG Energy Corp. (MEG:CA) is expected to report $0.95 for Q3 2023
Journey Energy Inc. (JOY:CA) is expected to report $0.08 for Q3 2023
Sandstorm Gold Ltd. (SSL:CA) is expected to report $0.01 for Q3 2023
PHX Energy Services Corp. (PHX:CA) is expected to report $0.35 for Q3 2023
Keg Royalties Income Fund (The) (KEG.UN:CA) is expected to report for Q3 2023
iMetal Resources Inc. (IMR:CA) is expected to report for Q2 2024
Victoria Gold Corp. (VGCX:CA) is expected to report $0.14 for Q3 2023
Finning International Inc. (FTT:CA) is expected to report $0.97 for Q3 2023
Salona Global Medical Device Corporation (SGMD:CA) is expected to report for Q3 2023
BTB Real Estate Investment Trust (BTB.UN:CA) is expected to report $0.11 for Q3 2023
Cardinal Energy Ltd. (CJ:CA) is expected to report $0.26 for Q3 2023
Fennec Pharmaceuticals Inc. (FRX:CA) is expected to report $-0.15 for Q3 2023